20 June 2013
Keywords: protherics, swings, loss, future, bright, uk-based, specializes
Article | 09 June 2003
UK-based Protherics, which specializes in the development of venom antidotes, has reported a robust increase in revenues for the first ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 May 2003
19 June 2013
© 2013 thepharmaletter.com